Meridian Bioscience, Inc. (VIVO) Stock Plummeted After Failing to Meet Financial Expectations for Preliminary Q3 2021 Results
Meridian Bioscience, Inc. (VIVO) stock prices plummeted by 22.53% some time after market trading commenced on July 13th, 2012, bringing the price per share down to USD$17.43 early on in the trading day. Suffering Financials July 13th, 2021 saw the provider of diagnostic testing solutions and life science raw materials announce preliminary revenue results for […]